Phase 2 trial shows sorfequiline with pretomanid and linezolid may enhance TB treatment efficacy and safety for drug-sensitive patients.

Tuberculosis cases have increased in Tulare County this year, which inspired the county’s Health & Human Services Agency to ...

Integrating tobacco-cessation services into HIV and tuberculosis care can enhance treatment outcomes and reduce mortality. Health systems should implement comprehensive tobacco-cessation strategies, ...

Pulmonary diseases pose a major health problem worldwide with millions of affected individuals and dire economic impact.

Initial blood work found hints of an infection, and the doctors initially suspected a bacterial skin infection (cellulitis) ...

By Sharon Atieno With tuberculosis (TB) treatment lasting about six to nine months, a new treatment regimen is set to reduce this period.A phase two clinical trial by TB Alliance has showed that a new ...

Tulane University professor of medicine Zhen Huang and his team of researchers have developed a simpler way to test for ...

A slew of new studies and reports suggest that new molecular approaches may soon help reduce the global burden of tuberculosis.

Global tuberculosis (TB) cases climbed again last year, reaching their highest level on record, according to new data from the World Health Organization (WHO).

Clinical trial results found that a new antibiotic candidate could shorten TB treatment from the standard 6 months to 8 weeks ...

New clinical trial results presented by TB Alliance at the Union World Conference on Lung Health show that the novel ...

A new TB drug, sorfequiline, shows promising results in a multinational trial, raising hopes for faster and simpler treatment ...